Status:
COMPLETED
Nocturnal Oxygen Treatment in Heart Failure and Cheyne-Stokes Respiration
Lead Sponsor:
Umeå University
Conditions:
Heart Failure
Eligibility:
All Genders
19-90 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether oxygen therapy during sleep improves quality of life, exercise capacity and heart function among patients with chronic heart failure and central sleep...
Detailed Description
Oxygen therapy reduces the number of central apneas among patients with congestive heart failure but it is unknown whether quality of life and heart function also improve. We aim to test whether the q...
Eligibility Criteria
Inclusion
- Stable heart failure with left ventricular dysfunction
- Cheyne-Stokes respiration with central AHI\>15 and obstructive AHI\<5
Exclusion
- Heart infarction within 3 months.
- Dementia
- Chronic obstructive pulmonary disease and daytime hypoxemia.
Key Trial Info
Start Date :
March 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00338078
Start Date
March 1 1999
End Date
December 1 2006
Last Update
July 2 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept of respiratory medicine
Umeå, Sweden, SE 901 85